Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
Sebastien Lobet, PhD at Saint-Luc University Clinics Cliniques, Co-founder of Activlim-Hemo, shared on LinkedIn:
”I had the honor of being invited to the Nordic Baltic Haemophilia Nurse and Physiotherapy Meeting, held over the past two days in Oslo.
I presented the ACTIVLIM-Hemo scale, a tool to assess activity limitations in adults with haemophilia, developed using a robust Rasch-based methodology.
The scale is unidimensional, linear, and reproducible, providing a reliable measure of functional performance.
ACTIVLIM-Hemo has been translated into 11 languages, with 5 already available.
It is freely accessible to all clinicians wishing to evaluate their patients’ activity limitations.
Developed by Prof. Massimo Penta (Arsalis and UCLouvain) and the Haematology Department of the Saint-Luc University Clinics Cliniques.
References:
Lobet S et al., Haemophilia, 2024. DOI: 10.1111/hae.14954
Lobet S et al., Haemophilia, 2023. DOI: 10.1111/hae.14705”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 15:51Mohammad Reza Moghaddasnejad: A New Chapter in Cancer Research – Exploring the Role of Platelets in Cancer Metastasis
-
Oct 17, 2026, 15:44James P. Crowley: Drs. Blumberg and Heal Win SABM Sazama Award for Transfusion Research
-
Oct 17, 2026, 15:41X. Long Zheng։ ADAMTS13 and VWF in COVID-19-Associated Coagulopathy
-
Oct 17, 2026, 14:59Diwakar Mittal: From Dialogue to Action: Advancing Sickle Cell Disease Care in India
-
Oct 17, 2026, 12:21Jalen Hurts Sidelined by a Superficial Blood Clot: What to Know
-
Oct 17, 2026, 09:33Robert Lookstein: Mechanical Thrombectomy Shows Functional Benefits in Intermediate-High-Risk PE
-
Oct 17, 2026, 09:18Sarra Hmidi: Tunisia Highlights Thrombosis Prevention on World Thrombosis Day
-
Oct 17, 2026, 09:05Addressing the Hidden Burden of Bleeding Disorders in Women – Hemophilia Society Mumbai Chapter
-
Oct 17, 2026, 08:49Maria Magnusson: Karolinska Experts Explore Gene Therapy in Sickle Cell Disease and Hemophilia